Allergy vaccine begins use in Russia
A new allergy vaccine has begun clinical application in Russia. The drug has already been administered to the first patients, marking an important stage in the treatment of allergic diseases.
A large-scale vaccination campaign is planned for the spring period. Doctors plan to vaccinate about 60,000 Russians, which will significantly reduce the prevalence of allergies among the population.
The new drug is considered a significant achievement in medicine for people suffering from various types of allergic reactions. The successful administration of the first doses gives hope for widespread implementation of the method.










